论文部分内容阅读
目的:研究红霉素联合中药雾化吸入在小儿支原体肺炎中的临床疗效,为临床提供依据。方法:选取2014年11月-2016年1月医院诊治的小儿支肺炎患者60例,根据治疗措施将患者分为对照组和观察组各30例,对照组采用红霉素治疗,观察组在对照组基础上联合中药雾化吸入治疗,比较两组临床疗效。结果:观察组退热时间、啰音消失时间、咳嗽消失时间,显著短于对照组(P<0.05);观察组不良反应发生率为10.0%,显著低于对照组的23.3%(P<0.05)。结论:小儿支原体肺炎在红霉素治疗基础上联合中药雾化吸入治疗效果理想,能缩短症状改善时间,值得推广应用。
Objective: To study the clinical efficacy of combined inhalation of erythromycin and traditional Chinese medicine in children with mycoplasma pneumonia and provide the basis for clinical practice. Methods: Sixty patients with pediatric pneumonia were selected from November 2014 to January 2016 in our hospital. According to the treatment measures, the patients were divided into control group and observation group with 30 cases each. The control group was treated with erythromycin. In the control group, Group based on the combination of atomization inhalation therapy, the clinical efficacy of two groups were compared. Results: The antipyretic time, the disappearance of rales and disappearance of cough in the observation group were significantly shorter than those in the control group (P <0.05). The adverse reaction rate in the observation group was 10.0%, significantly lower than that in the control group (23.3%, P <0.05) ). Conclusion: Mycoplasma pneumonia in children with erythromycin in combination with traditional Chinese medicine atomization inhalation therapy is effective, can shorten the time to improve symptoms, it is worth promoting.